# Nicotine Vaccination and Nicotinic Receptor Occupancy

> **NCT00996034** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 14 (actual)

## Conditions studied

- Nicotine Dependence

## Interventions

- **BIOLOGICAL:** NicVAX
- **RADIATION:** [123I]5-IA-85380
- **DRUG:** Nicotine bitartrate

## Key facts

- **NCT ID:** NCT00996034
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2015-12-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00996034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00996034, "Nicotine Vaccination and Nicotinic Receptor Occupancy". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00996034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*